Verily

The page describes stop-loss insurance for self-funded employee health benefits that combines data analytics, multi-year protection, and health management innovations.

Pre, the AI-native platform for precision health, processes diverse, multimodal data and enables advanced analytics, workflow orchestration, and AI deployment.

Verily Onduo has been discontinued, and Verily Lightpath is a care program for existing members and new employer or health plan clients.

Wastewater-based pathogen testing and data insights to combat infectious disease

Alix Hart is the Chief Marketing Officer at Verily where she leads all marketing activities for brand, communications, product marketing and digital, which includes the marketing services that deliver personalized recruitment and engagement for Verily’s p

The page describes Verily's leadership team and its mission to make healthcare more personal and precise.

Stephen Gillett is the Chief Executive Officer & Chairman of the Board at Verily, where he leads multi-disciplinary health, technology and business teams to advance the company's precision health purpose.

Utpal Koppikar is the Chief Financial Officer at Verily, where he's responsible for the finance, real estate and workplace services (REWS) and corporate development functions

Verily combines clinical expertise, data science, and technology to bring precision health to everyone.

Verily's Pre is an AI-native platform for precision health.

Verily's AI-native data platform unifies complex health data with governance to support research and care for precision health.

Verily is a precision health company that helps pharma and consumer health companies develop safe, effective treatments faster and enable patients, providers and payors to make better care decisions

Verily Health secures a Centers for Disease Control and Prevention (CDC) contract to enhance national infectious disease tracking through wastewater surveillance. The agreement expands pathogen testing, genomic sequencing, and metagenomic capabilities to improve early detection and public health monitoring. This initiative leverages advanced bioinformatics to analyze wastewater samples for disease trends across the U.S.

Oct 2026Wapakoneta Daily NewsNews article

Verily Health secures additional funding from NVIDIA and the CU Healthcare Innovation Fund II, LP as part of an extended March fundraising round. The company’s existing investors include Alphabet, Series X Capital, and UCHealth. Verily expands its financial backing to support its healthcare innovation initiatives.

Sep 2026Yahoo FinanceNews article

Verily secures **$300 million** in a funding round led by **Series X Capital** to expand its **precision health AI** initiatives. The investment supports the company’s next-phase strategy in AI-driven healthcare solutions. Verily continues to focus on leveraging artificial intelligence to improve medical diagnostics and patient outcomes.

May 2026Medical Product OutsourcingNews article

Verily raises $300 million in funding to expand its AI-driven precision health initiatives. The investment, led by Series X Capital, supports the development of advanced health technologies. The company focuses on leveraging artificial intelligence to improve personalized medical solutions.

Mar 2026ITDigestNews article